Literature DB >> 9125311

Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.

T Korhonen1, M J Savolainen, M J Koistinen, M Ikäheimo, M K Linnaluoto, K Kervinen, Y A Kesäniemi.   

Abstract

The differences between the lipid profiles of male and female patients and the effect of plasma lipids on the extent of coronary artery disease were evaluated in 122 angiographically assessed coronary artery disease patients (95 males and 27 females) and 60 controls. Both male and female patients had lower HDL-cholesterol and higher total cholesterol, LDL-cholesterol, triglyceride, VLDL-cholesterol and VLDL-triglyceride concentrations than the controls. The VLDL lipid values did not differ significantly between the male patients with different extent of CAD, whereas the VLDL lipid values of female patients tended to increase with an increasing severity of CAD. High Lp(a) (> or = 35 mg/dl) values were more prevalent in patients with > 50% coronary stenosis compared to patients with < 50% stenosis and the controls (29%, 17% and 12%, respectively). The apolipoprotein E phenotypes and epsilon allele frequencies were similar in the patients and the controls. Low HDL-cholesterol and high LDL-cholesterol are CAD risk factors for both sexes. For women, elevated VLDL-triglycerides seem to be an additional risk factor for CAD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9125311     DOI: 10.1016/s0021-9150(96)05958-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Homocysteine and markers of inflammation in acute coronary syndrome.

Authors:  Mabrouka El Oudi; Zied Aouni; Chakib Mazigh; Radhia Khochkar; Ezzeddine Gazoueni; Habib Haouela; Salem Machghoul
Journal:  Exp Clin Cardiol       Date:  2010

2.  Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks.

Authors:  Aurélie Gaasch; Stephan Schönecker; Cristoforo Simonetto; Markus Eidemüller; Montserrat Pazos; Daniel Reitz; Maya Rottler; Philipp Freislederer; Michael Braun; Rachel Würstlein; Nadia Harbeck; Maximilian Niyazi; Claus Belka; Stefanie Corradini
Journal:  Radiat Oncol       Date:  2020-05-24       Impact factor: 3.481

3.  Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.

Authors:  Christos Markopoulos; Urania Dafni; John Misitzis; Vasilios Zobolas; Evagelos Tzoracoleftherakis; Dimitrios Koukouras; Grigorios Xepapadakis; John Papadiamantis; Basileios Venizelos; Zoh Antonopoulou; Helen Gogas
Journal:  Breast Cancer Res       Date:  2009-06-16       Impact factor: 6.466

Review 4.  The effects of aromatase inhibitors on lipids and thrombosis.

Authors:  N J Bundred
Journal:  Br J Cancer       Date:  2005-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.